By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.
In a new paper titled "Calcium imaging and analysis of the jugular-nodose ganglia enables identification of distinct vagal sensory neuron subsets," published in the Journal of Neural Engineering, investigators focused their attention on sensory neurons of the peripheral nervous system.
They wanted to know how these neurons encode and interpret different stimuli in the form of neural activity.
The researchers used imaging of the intact jugular-nodose ganglion which contains the sensory neurons of the vagus nerve to directly record neural activity in mice with genetically-encoded calcium indicators.
They then analyzed the signals and used a machine learning algorithm to classify the neuronal responses to different types of chemical stimuli applied to the vagus nerve.
They found that specific neuronal responses were closely associated with certain types of stimuli, reflecting an encoding of information within the PNS, before further transmission to the brain.
Led by Eric H. Chang, PhD, and postdoctoral researcher Tomás S. Huerta, PhD, the study is part of a multi-year USD 1.3m grant from the National Institutes of Health to examine how immune signals are transmitted to the brain through the vagus nerve.
The vagus nerve is often referred to as the body's superhighway it connects the brain with all major organs, and controls functions like heart rate, breathing and gastrointestinal function. When the nerve is stimulated, it can reduce inflammation, which is a trigger for many diseases, and help the body's immune system.
Inflammation is an important immune response, however if uncontrolled, can lead to serious conditions such as Crohn's disease, rheumatoid arthritis and other chronic inflammatory disorders.
In this new study, Feinstein Institutes' bioelectronic medicine researchers look at how sensory neurons encode and transmit these important physiological signals in the form of neural activity.
This information can be used for future research to develop new bioelectronic medicine devices, like vagus nerve stimulators, and better advance our methods to control the signals between the brain and body.
The Feinstein Institutes for Medical Research is a global scientific home of bioelectronic medicine, which combines molecular medicine, neuroscience and biomedical engineering.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system